HAYLEE MARTIN: Open Payments
NPI 1528808508 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,145 in 51 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $450 · 2025 $1,145
Food & beverage: $1,145
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $416 |
| AstraZeneca Pharmaceuticals LP | 6 | $137 |
| Otsuka America Pharmaceutical, Inc. | 4 | $87 |
| ABBVIE INC. | 3 | $62 |
| Amgen Inc. | 3 | $51 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| Lilly USA, LLC | 2 | $40 |
| Abbott Laboratories | 2 | $33 |
| Antares Pharma, Inc. | 1 | $30 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
Products named: Ozempic, REXULTI, FARXIGA, Wegovy, TRELEGY ELLIPTA, MOUNJARO, EVENITY, VRAYLAR.
Industry payments across GA — which companies pay providers there.
